Error loading player: No playable sources found

2410

Basic Mechanism of Tissue Repair and Injury

Date
May 18, 2024

SOCIETY: AGA

Presentations:

TFF2+ GASTRIC CORPUS PROGENITORS DIRECTLY CONTRIBUTE TO THE DEVELOPMENT OF METAPLASIA/SPEM
EPITHELIAL-DERIVED NADPH OXIDASE (NOX)-1 IN ENTERAL GLUCOSE-MEDIATED RESTORATION OF CRYPT ACTIVITY AND REINFORCEMENT OF BARRIER FUNCTION IN ISCHEMIC JEJUNUM
DUAL ACTIVATION OF GCGR/GLP1R SIGNALING AMELIORATES INTESTINAL FIBROSIS VIA METABOLIC REGULATION OF HISTONE H3K9 LACTYLATION IN EPITHELIAL CELLS
BRD4 AS A POTENTIAL THERAPEUTIC TARGET FOR CROHN’S DISEASE-ASSOCIATED FIBROSIS
CHARACTERIZATION OF PATIENT-DERIVED INTESTINAL ORGANOIDS FOR MODELING FIBROSIS IN INFLAMMATORY BOWEL DISEASE
INTER-ORGAN TRANSCRIPTOME HETEROGENEITY OF FIBROBLASTS IN THE GASTROINTESTINAL TRACT REVEALS POTENTIAL MECHANISMS UNDERLYING OESOPHAGEAL STRICTURE.

Moderators

Speaker Image for Andrei Ivanov
Virginia Commonwealth University
Speaker Image for Jennifer Foulke-Abel
Johns Hopkins University

Related Products

Thumbnail for Irritable Bowel Syndrome in Inflammatory Bowel Disease: Boundaries Along a Continuum
Irritable Bowel Syndrome in Inflammatory Bowel Disease: Boundaries Along a Continuum
SOCIETY: AGA IBS-like symptoms in patients with IBD are common, yet presenting a diagnostic and clinical challenge for patients and their providers…
Thumbnail for AGA Beyond Gut Bacteria: Transkingdom Interactions Underlying GI Diseases
AGA Beyond Gut Bacteria: Transkingdom Interactions Underlying GI Diseases
Through the history of gut microbiome research, basic, translational, and clinical studies revealed many critical roles played by gut-resident bacteria in affecting human health and disease…
Thumbnail for Gut Microbiome — Ally or Foe for Immune Checkpoint Inhibitors
Gut Microbiome — Ally or Foe for Immune Checkpoint Inhibitors
SOCIETY: AGA This session will explore the complex dynamics between the gut microbiome and immune checkpoint inhibitors, addressing whether specific microbes/metabolites enhance therapeutic outcomes acting as allies or present challenges as potential foes, impacting treatment efficacy and associate…